个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo(1,5-a)pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach

  作者 KOSUGI TOMOMI; MITCHELL DALE R; FUJINO AIKO; IMAI MINORU; KAMBE MIKA; KOBAYASHI SHINJI; MAKINO HIROAKI; MATSUEDA YOHEI; OUE YASUHIRO; KOMATSU KANJI; IMAIZUMI KEIICHIRO; SAKAI YURI; SUGIURA SATOSHI; TAKENOUCHI OSAMI; UNOKI GEN; YAMAKOSHI YUKO; CUNLIFFE VICKY; FREARSON JULIE; GORDON RICHARD; HARRIS C JOHN; KALLOOHOSEIN HEIDI; LE JOELLE; PATEL GITA; SIMPSON DONALD J; SHERBORNE BRAD; THOMAS PETER S; SUZUKI NAOTAKA; TAKIMOTOKAMIMURA MIDORI; KATAOKA KENICHIRO  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2012年55-15;  页码  6700-6715  
  关联知识点  
 

[摘要]A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the observed selectivity over CDK2. An X-ray crystal structure of a compound from the active series bound to crystalline MAPKAP-K2 confirmed the predicted binding mode. This has enabled the discovery of a series of pyrazolo[1,5-a] pyrimidine derivatives showing good in vitro cellular potency as anti-TNF-alpha agents and in vivo efficacy in a mouse model of endotoxin shock.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内